WEST LAFAYETTE, Ind., Aug. 7, 2012 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that Ron Ellis, president and CEO of Endocyte, will present at the Wedbush PacGrow Life Sciences Management Access Conference on Wednesday, Aug. 15, at 2:30 p.m. EDT. The conference is being held at the Le Parker Meridien, New York.
